Tyrosine kinase inhibitor-induced carotid stenosis: A case report

Tyrosine kinase inhibitors are considered as highly effective and relatively safe drugs for the treatment of chronic myeloid leukemia. If several side effects on short and long term are well known and described, their involvement in the development of carotid stenosis remains unclear. Here, we descr...

Descripción completa

Detalles Bibliográficos
Autores principales: Hersant, Jeanne, Gardembas, Martine, Leftheriotis, Georges, Vandeputte, Patrick, Abraham, Pierre, Henni, Samir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6551505/
https://www.ncbi.nlm.nih.gov/pubmed/31194170
http://dx.doi.org/10.1016/j.lrr.2019.100171
_version_ 1783424403929825280
author Hersant, Jeanne
Gardembas, Martine
Leftheriotis, Georges
Vandeputte, Patrick
Abraham, Pierre
Henni, Samir
author_facet Hersant, Jeanne
Gardembas, Martine
Leftheriotis, Georges
Vandeputte, Patrick
Abraham, Pierre
Henni, Samir
author_sort Hersant, Jeanne
collection PubMed
description Tyrosine kinase inhibitors are considered as highly effective and relatively safe drugs for the treatment of chronic myeloid leukemia. If several side effects on short and long term are well known and described, their involvement in the development of carotid stenosis remains unclear. Here, we describe a case of carotid stenosis in a patient receiving tyrosine kinase inhibitors and discuss the current literature.
format Online
Article
Text
id pubmed-6551505
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-65515052019-06-10 Tyrosine kinase inhibitor-induced carotid stenosis: A case report Hersant, Jeanne Gardembas, Martine Leftheriotis, Georges Vandeputte, Patrick Abraham, Pierre Henni, Samir Leuk Res Rep Article Tyrosine kinase inhibitors are considered as highly effective and relatively safe drugs for the treatment of chronic myeloid leukemia. If several side effects on short and long term are well known and described, their involvement in the development of carotid stenosis remains unclear. Here, we describe a case of carotid stenosis in a patient receiving tyrosine kinase inhibitors and discuss the current literature. Elsevier 2019-05-25 /pmc/articles/PMC6551505/ /pubmed/31194170 http://dx.doi.org/10.1016/j.lrr.2019.100171 Text en © 2019 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Article
Hersant, Jeanne
Gardembas, Martine
Leftheriotis, Georges
Vandeputte, Patrick
Abraham, Pierre
Henni, Samir
Tyrosine kinase inhibitor-induced carotid stenosis: A case report
title Tyrosine kinase inhibitor-induced carotid stenosis: A case report
title_full Tyrosine kinase inhibitor-induced carotid stenosis: A case report
title_fullStr Tyrosine kinase inhibitor-induced carotid stenosis: A case report
title_full_unstemmed Tyrosine kinase inhibitor-induced carotid stenosis: A case report
title_short Tyrosine kinase inhibitor-induced carotid stenosis: A case report
title_sort tyrosine kinase inhibitor-induced carotid stenosis: a case report
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6551505/
https://www.ncbi.nlm.nih.gov/pubmed/31194170
http://dx.doi.org/10.1016/j.lrr.2019.100171
work_keys_str_mv AT hersantjeanne tyrosinekinaseinhibitorinducedcarotidstenosisacasereport
AT gardembasmartine tyrosinekinaseinhibitorinducedcarotidstenosisacasereport
AT leftheriotisgeorges tyrosinekinaseinhibitorinducedcarotidstenosisacasereport
AT vandeputtepatrick tyrosinekinaseinhibitorinducedcarotidstenosisacasereport
AT abrahampierre tyrosinekinaseinhibitorinducedcarotidstenosisacasereport
AT hennisamir tyrosinekinaseinhibitorinducedcarotidstenosisacasereport

Ejemplares similares